| Literature DB >> 34910894 |
Mengyang Xu1,2,3,4, Binshi Bo5, Mengchao Pei5, Yuyan Chen5, Christina Y Shu6,7, Qikai Qin1,2,3, Lydiane Hirschler8,9, Jan M Warnking8, Emmanuel L Barbier8, Zhiliang Wei10,11, Hanzhang Lu10,11, Peter Herman7,12,13, Fahmeed Hyder6,7,12,13, Zhi-Jie Liu1,2,3, Zhifeng Liang5, Garth J Thompson1.
Abstract
Functional magnetic resonance imaging (fMRI) techniques using the blood-oxygen level-dependent (BOLD) signal have shown great potential as clinical biomarkers of disease. Thus, using these techniques in preclinical rodent models is an urgent need. Calibrated fMRI is a promising technique that can provide high-resolution mapping of cerebral oxygen metabolism (CMRO2). However, calibrated fMRI is difficult to use in rodent models for several reasons: rodents are anesthetized, stimulation-induced changes are small, and gas challenges induce noisy CMRO2 predictions. We used, in mice, a relaxometry-based calibrated fMRI method which uses cerebral blood flow (CBF) and the BOLD-sensitive magnetic relaxation component, R2', the same parameter derived in the deoxyhemoglobin-dilution model of calibrated fMRI. This method does not use any gas challenges, which we tested on mice in both awake and anesthetized states. As anesthesia induces a whole-brain change, our protocol allowed us to overcome the former limitations of rodent studies using calibrated fMRI. We revealed 1.5-2 times higher CMRO2, dependent upon brain region, in the awake state versus the anesthetized state. Our results agree with alternative measurements of whole-brain CMRO2 in the same mice and previous human anesthesia studies. The use of calibrated fMRI in rodents has much potential for preclinical fMRI.Entities:
Keywords: Awake mice; CMRO2; TRUST; anesthesia; calibrated fMRI; dexmedetomidine; pCASL
Mesh:
Substances:
Year: 2021 PMID: 34910894 PMCID: PMC9014688 DOI: 10.1177/0271678X211062279
Source DB: PubMed Journal: J Cereb Blood Flow Metab ISSN: 0271-678X Impact factor: 6.960